A randomised controlled trial of the efficacy and safety of allopurinol dose escalation to achieve target serum urate in people with gout

Overview of attention for article published in Annals of the Rheumatic Diseases, March 2017

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (94th percentile)
High Attention Score compared to outputs of the same age and source (82nd percentile)

Mentioned by

news: 2 news outlets
policy: 2 policy sources
twitter: 11 X users

reddit: 1 Redditor
guideline: 1 clinical guideline source
podcasts: 1 podcast

Readers on

mendeley: 98 Mendeley

So far, Altmetric has seen 12 X posts from 11 X users, with an upper bound of 36,956 followers.

El ensayo original, pero no esta en abierto https://t.co/pzQVagpVyT

RT @pinacol: この文献からGFRが下がってきたからといって今飲んでいるアロプリノールの量を減らす必要は無さそうという個人的考え。 A randomised controlled trial of the efficacy and safety of allopur…

この文献からGFRが下がってきたからといって今飲んでいるアロプリノールの量を減らす必要は無さそうという個人的考え。 A randomised controlled trial of the efficacy and safety of allopurinol dose escalation to achieve target serum urate in people with gout http…

More science, less fear RCT Efficacy&Safety of allopurinol dose escalation to achieve target SUA in people with gout https://t.co/hcVDNEYrs1

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 8 additional X posts.